Relationship register · Organisation

Triumvira Immunologics

Triumvira Immunologics is a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors.

Official website: triumvira.com
Relationship register: 3 documented relationships

Documented relationships

3 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Robert F. Williamson, IIIEmploymentTriumvira Immunologics
Reported^{3Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapiestriumvira.com}
Role or entity indicated by the source: “President and COO”.
Mr. Robert WilliamsonEmploymentTriumvira Immunologics
July 20, 2023Reported^{2Triumvira Immunologics Strengthens its Leadership Team with Three Accomplished Life Sciences Executives - Triumvira Immunologics | Engineered T Cell Therapiestriumvira.com}
Role or entity indicated by the source: “President, Chief Operating Officer”.
Mr. Robert WilliamsonBoard seatTriumvira Immunologics
July 20, 2023Reported^{2Triumvira Immunologics Strengthens its Leadership Team with Three Accomplished Life Sciences Executives - Triumvira Immunologics | Engineered T Cell Therapiestriumvira.com}
Role or entity indicated by the source: “member of the Board of Directors”.

Sources

1.
Home - Triumvira Immunologics | Engineered T Cell Therapies
Web pagetriumvira.com
View original ↑ Back to text
2.
Triumvira Immunologics Strengthens its Leadership Team with Three Accomplished Life Sciences Executives - Triumvira Immunologics | Engineered T Cell Therapies
Web pagetriumvira.com
View original ↑ Back to text
3.
Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapies
Web pagetriumvira.com
View original ↑ Back to text